Victrex (LON:VCT) Stock Passes Above Two Hundred Day Moving Average – Should You Sell?

Shares of Victrex plc (LON:VCT) crossed above its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of GBX 998.70 ($12.15) and traded as high as GBX 1,056 ($12.85). Victrex shares last traded at GBX 1,046 ($12.73), with a volume of 28,260,615 shares traded.

Analyst Upgrades and Downgrades

Separately, Berenberg Bank decreased their price objective on shares of Victrex from GBX 1,290 ($15.70) to GBX 1,170 ($14.24) and set a “hold” rating for the company in a report on Wednesday, December 4th.

Victrex Price Performance

The company has a 50 day moving average of GBX 1,004.40 and a two-hundred day moving average of GBX 997.27. The firm has a market cap of £924.26 million, a P/E ratio of 3,034.29, a PEG ratio of 1.92 and a beta of 0.69. The company has a quick ratio of 1.99, a current ratio of 5.30 and a debt-to-equity ratio of 16.99.

Victrex Increases Dividend

The firm also recently disclosed a dividend, which will be paid on Friday, February 21st. Stockholders of record on Thursday, January 23rd will be given a dividend of GBX 46.14 ($0.56) per share. This is a positive change from Victrex’s previous dividend of $13.42. The ex-dividend date of this dividend is Thursday, January 23rd. This represents a dividend yield of 5.26%. Victrex’s dividend payout ratio (DPR) is 17,142.86%.

Insider Buying and Selling

In related news, insider Ian Melling bought 2,000 shares of the business’s stock in a transaction dated Friday, December 13th. The shares were bought at an average cost of GBX 1,135 ($13.81) per share, with a total value of £22,700 ($27,618.93). Also, insider Brendan Connolly bought 980 shares of Victrex stock in a transaction dated Tuesday, December 3rd. The shares were bought at an average cost of GBX 1,019 ($12.40) per share, with a total value of £9,986.20 ($12,150.14). Insiders own 1.64% of the company’s stock.

Victrex Company Profile

Victrex plc, through its subsidiaries, engages in the manufacture and sale of polymer solutions worldwide. The company operates through two segments, Sustainable Solutions and Medical. It develops PEEK and PAEK based polymer solutions, and semi-finished and finished parts. The company also provides specialist solutions for medical device manufacturers; sells thermoplastic polymers; sustainable solutions for energy and industrial, VAR, automotive, aerospace, and electronics markets; and engages in trading activities.